Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration

NCT01027468 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG: Bevacizumab

Sponsor

Medical University of Vienna